Explore the revolutionary PROTAC technology targeting CDKs for breast cancer treatment - from inhibition to complete protein degradation.
Discover how PROTAC-STAN, an AI-powered framework, is transforming targeted protein degradation to combat previously undruggable diseases through interpretable predictions.
Explore the revolutionary approach of PROTAC-based HDAC degradation in epigenetic cancer therapy, moving beyond inhibition to complete protein elimination.
Novel endoxifen-based PROTAC molecules synergize with olaparib to fight triple negative breast cancer through induction of DNA damage
Explore the revolutionary PROTAC technology targeting alpha-synuclein for Parkinson's disease treatment through molecular degradation.
Discover how PROTAC technology is revolutionizing cancer therapy by targeting MLK3 in triple-negative breast cancer, offering hope against treatment-resistant tumors.
Discover how PROTAC technology revolutionized our understanding of FAK protein's non-enzymatic functions in fertility and cancer research.
Explore how PROTACs are revolutionizing medicine by targeting previously 'undruggable' proteins for degradation, with clinical breakthroughs in cancer and neurodegenerative diseases.